Trachoma: Clinical Trials

2 trials for Trachoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1
Phase 31Withdrawn 1

Follow Trachoma: new trials by email Literature Review of Trachoma trials Research Report on Trachoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma
IR3535, Permethrin lower dose, Permethrin higher dose - Trachoma
Phase 2CompletedLondon School of Hygiene and Tropical Medicine642019-01-102020-04-08
Nepal Elimination of Trachoma Study
Azithromycin - Trachoma
Phase 2 / Phase 3WithdrawnUniversity of California, San Francisco2014-08-012015-05-21

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Chlamydia Infections (2)  ·  Chlamydiaceae Infections (2)  ·  Conjunctival Diseases (2)  ·  Conjunctivitis (2)  ·  Conjunctivitis, Bacterial (2)  ·  Corneal Diseases (2)  ·  Eye Diseases (2)  ·  Eye Infections (2)  ·  Eye Infections, Bacterial (2)  ·  Gram-Negative Bacterial Infections (2)  ·  Infections (2)

Interventions

Azithromycin (1)  ·  Permethrin (1)  ·  ethyl-3-(N-n-butyl-N-acetyl)aminopropionate (1)

Sponsors

London School of Hygiene and Tropical Medicine (1)  ·  University of California, San Francisco (1)

Countries

Ethiopia (1)  ·  Nepal (1)  ·  United Kingdom (1)

Top investigators

Bruce D Gaynor, MD (1)

Results publications

PMID 35747196

NIH funding

K23EY019881 (1)